Skip to main content

Table 3 Number and percentage of significant DMPs in COST DMRs

From: Genome-wide methylation profiling of Beckwith-Wiedemann syndrome patients without molecular confirmation after routine diagnostics

Patient_ID

Number of significant DMPs

Number of significant DMPs in COST DMR

% significant DMPs in COST DMPs

MLID BWS5

857

154

17.97

MLID BWS3

1903

226

11.88

MLID BWS1

1668

138

8.27

MLID BWS2

2779

161

5.79

MLID BWS4

1742

65

3.73

BWS7

1957

41

2.10

BWS22

1055

16

1.52

BWS25

9146

109

1.19

BWS5

1333

8

0.60

BWS24

13,898

77

0.55

BWS11

1102

6

0.54

BWS4

834

4

0.48

BWS23

476

2

0.42

BWS3

615

2

0.33

BWS1

1084

3

0.28

BWS16

441

1

0.23

BWS9

903

2

0.22

BWS12

474

1

0.21

BWS18

538

1

0.19

BWS17

545

1

0.18

BWS8

701

1

0.14

BWS10

1517

2

0.13

BWS13

479

0

0.00

BWS14

443

0

0.00

BWS15

551

0

0.00

BWS19

538

0

0.00

BWS20

419

0

0.00

BWS21

463

0

0.00

BWS2

735

0

0.00

BWS6

621

0

0.00